MolNFT v1 · #136236 · protein
Crystal structure of TNMS1, an antibiotic binding protein from streptomyces sp. CB03234
5UMQ · GLYOXALASE/BLEOMYCIN resisance PROTEIN/DIOXYGENASE: “Crystal structure of TNMS1, an antibiotic binding protein from streptomyces sp. CB03234”. X-ray diffraction, 2 pockets (best druggability 0.57). MolNFT v1 #136236 on GenesisL1: 3D…
- PDB
- 5UMQ
- Type
- protein
- Length
- 251 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- GLYOXALASE/BLEOMYCIN resisance PROTEIN/DIOXYGENASE
- UniProt
- A0A125SA24
- Pockets
- 2 · best druggability 0.57
Structure
x-ray diffraction · 2 distinct chains · 17% helix, 46% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | GLYOXALASE/BLEOMYCIN resisance PROTEIN/DIOXYGENASE | protein | 125 | 17% helix, 47% strand | A0A125SA24 |
| B | GLYOXALASE/BLEOMYCIN resisance PROTEIN/DIOXYGENASE | protein | 126 | 17% helix, 45% strand | A0A125SA24 |
Pockets
2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 278 | 0.57 | 0.77 | 39 | empty |
| 2 | 247 | 0.55 | 0.77 | 30 | empty |
Interfaces
1 interface between chains.
- A–B · 1871 Ų buried · 29 hydrogen bonds · protein-protein
Compared structures
- 5UMQ · Crystal structure of TnmS1, an antibiotic binding protein from Streptomyces sp. CB03234 · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt A0A125SA24
- Elsewhere: RCSB PDB 5UMQ · PDBe 5UMQ · UniProt A0A125SA24
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.